Cargando…

A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications

INTRODUCTION: The need for detection of new and recent HIV infections is essential for surveillance and assessing interventions in controlling the epidemic. HIV recency assays are one way of providing reliable incidence estimates by determining recent versus non-recent infection. The objective of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kin-On Lau, Joseph, Murdock, Nicholas, Murray, Jeffrey, Justman, Jessica, Parkin, Neil, Miller, Veronica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482108/
https://www.ncbi.nlm.nih.gov/pubmed/36124229
http://dx.doi.org/10.1016/j.jve.2022.100085
_version_ 1784791380216774656
author Kin-On Lau, Joseph
Murdock, Nicholas
Murray, Jeffrey
Justman, Jessica
Parkin, Neil
Miller, Veronica
author_facet Kin-On Lau, Joseph
Murdock, Nicholas
Murray, Jeffrey
Justman, Jessica
Parkin, Neil
Miller, Veronica
author_sort Kin-On Lau, Joseph
collection PubMed
description INTRODUCTION: The need for detection of new and recent HIV infections is essential for surveillance and assessing interventions in controlling the epidemic. HIV recency assays are one way of providing reliable incidence estimates by determining recent versus non-recent infection. The objective of this study was to review the current body of knowledge of the limiting antigen avidity enzyme immunoassay to expand supported applications through an assessment of what is known and the gaps. METHODS: A search for peer-reviewed literature in PubMed, Embase, and Web of Science Core Collection was conducted using the search term “human immunodeficiency virus and avidity”. Non-peer reviewed published reports from the Population-based HIV Impact Assessment Project were also included. These were limited to literature published in English between January 2010 and August 2021. RESULTS: This search resulted in 2080 publications and 14 reports, with 137 peer-reviewed studies and 14 non-peer reviewed reports that met the inclusion criteria, yielding a total of 151 studies for the final review. There were similar findings among studies that compared the performances of assay manufacturers and sample types. Studies that evaluated various assay algorithms and thresholds were heterogeneous, illustrating the need for context-specific test characteristics for classifying recent infections. Most studies estimated subtype-specific test characteristics for HIV subtypes A, B, C, and D. This was further illustrated when looking only at studies that compared HIV incidence estimates from recency assay algorithms and longitudinal cohorts. CONCLUSIONS: These findings suggest that the current body of knowledge provides important information that contributes towards distinguishing recent and non-recent infection and incidence estimation. However, there are knowledge gaps with respect to factors that influence the test characteristics (e.g., HIV-1 subtype, population characteristics, assay algorithms and thresholds). Further studies are needed to estimate and establish context-specific test characteristics that consider these influencing factors to improve and expand the use of this assay for detection of recent HIV infection.
format Online
Article
Text
id pubmed-9482108
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-94821082022-09-18 A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications Kin-On Lau, Joseph Murdock, Nicholas Murray, Jeffrey Justman, Jessica Parkin, Neil Miller, Veronica J Virus Erad Review INTRODUCTION: The need for detection of new and recent HIV infections is essential for surveillance and assessing interventions in controlling the epidemic. HIV recency assays are one way of providing reliable incidence estimates by determining recent versus non-recent infection. The objective of this study was to review the current body of knowledge of the limiting antigen avidity enzyme immunoassay to expand supported applications through an assessment of what is known and the gaps. METHODS: A search for peer-reviewed literature in PubMed, Embase, and Web of Science Core Collection was conducted using the search term “human immunodeficiency virus and avidity”. Non-peer reviewed published reports from the Population-based HIV Impact Assessment Project were also included. These were limited to literature published in English between January 2010 and August 2021. RESULTS: This search resulted in 2080 publications and 14 reports, with 137 peer-reviewed studies and 14 non-peer reviewed reports that met the inclusion criteria, yielding a total of 151 studies for the final review. There were similar findings among studies that compared the performances of assay manufacturers and sample types. Studies that evaluated various assay algorithms and thresholds were heterogeneous, illustrating the need for context-specific test characteristics for classifying recent infections. Most studies estimated subtype-specific test characteristics for HIV subtypes A, B, C, and D. This was further illustrated when looking only at studies that compared HIV incidence estimates from recency assay algorithms and longitudinal cohorts. CONCLUSIONS: These findings suggest that the current body of knowledge provides important information that contributes towards distinguishing recent and non-recent infection and incidence estimation. However, there are knowledge gaps with respect to factors that influence the test characteristics (e.g., HIV-1 subtype, population characteristics, assay algorithms and thresholds). Further studies are needed to estimate and establish context-specific test characteristics that consider these influencing factors to improve and expand the use of this assay for detection of recent HIV infection. Elsevier 2022-09-07 /pmc/articles/PMC9482108/ /pubmed/36124229 http://dx.doi.org/10.1016/j.jve.2022.100085 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Kin-On Lau, Joseph
Murdock, Nicholas
Murray, Jeffrey
Justman, Jessica
Parkin, Neil
Miller, Veronica
A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications
title A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications
title_full A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications
title_fullStr A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications
title_full_unstemmed A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications
title_short A systematic review of limiting antigen avidity enzyme immunoassay for detection of recent HIV-1 infection to expand supported applications
title_sort systematic review of limiting antigen avidity enzyme immunoassay for detection of recent hiv-1 infection to expand supported applications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482108/
https://www.ncbi.nlm.nih.gov/pubmed/36124229
http://dx.doi.org/10.1016/j.jve.2022.100085
work_keys_str_mv AT kinonlaujoseph asystematicreviewoflimitingantigenavidityenzymeimmunoassayfordetectionofrecenthiv1infectiontoexpandsupportedapplications
AT murdocknicholas asystematicreviewoflimitingantigenavidityenzymeimmunoassayfordetectionofrecenthiv1infectiontoexpandsupportedapplications
AT murrayjeffrey asystematicreviewoflimitingantigenavidityenzymeimmunoassayfordetectionofrecenthiv1infectiontoexpandsupportedapplications
AT justmanjessica asystematicreviewoflimitingantigenavidityenzymeimmunoassayfordetectionofrecenthiv1infectiontoexpandsupportedapplications
AT parkinneil asystematicreviewoflimitingantigenavidityenzymeimmunoassayfordetectionofrecenthiv1infectiontoexpandsupportedapplications
AT millerveronica asystematicreviewoflimitingantigenavidityenzymeimmunoassayfordetectionofrecenthiv1infectiontoexpandsupportedapplications
AT kinonlaujoseph systematicreviewoflimitingantigenavidityenzymeimmunoassayfordetectionofrecenthiv1infectiontoexpandsupportedapplications
AT murdocknicholas systematicreviewoflimitingantigenavidityenzymeimmunoassayfordetectionofrecenthiv1infectiontoexpandsupportedapplications
AT murrayjeffrey systematicreviewoflimitingantigenavidityenzymeimmunoassayfordetectionofrecenthiv1infectiontoexpandsupportedapplications
AT justmanjessica systematicreviewoflimitingantigenavidityenzymeimmunoassayfordetectionofrecenthiv1infectiontoexpandsupportedapplications
AT parkinneil systematicreviewoflimitingantigenavidityenzymeimmunoassayfordetectionofrecenthiv1infectiontoexpandsupportedapplications
AT millerveronica systematicreviewoflimitingantigenavidityenzymeimmunoassayfordetectionofrecenthiv1infectiontoexpandsupportedapplications